B-Complex Tablets
B-Complex Tablets, licence 80144052: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Other names
- Pharmaline B-Complex Tablets
- Licence holder
- Pharmaline Inc.
- NPN or DIN-HM
- 80144052
- Status
- Active licence
- Licence date
- 11 September 2025
- Revision date
- Not provided
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Acide pantothénique Source : D-Pantothénate de calcium | 3.0 mg | 3,000 µg |
| Thiamine Source : Chlorhydrate de thiamine | 2.0 mg | 2,000 µg |
| Riboflavine Source : Riboflavine | 2.0 mg | 2,000 µg |
| Vitamine B6 Source : Chlorhydrate de pyridoxine | 2.0 mg | 2,000 µg |
| Niacinamide Source : Niacinamide | 25.0 mg | Not calculated |
Non-medicinal ingredients
Dioxyde de titane, Talc, Cellulose microcristalline, Poly(éthylène glycol), Hypromellose, Poly(alcool vinylique), Phosphate de dicalcium dihydraté, Dioxyde de silicium, Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | 18 ans | 1.0 Comprimé | 1.0 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
A factor in normal growth and development. A factor in the maintenance of good health. Contributes to maintaining general health. For maintaining general health. Helps in energy metabolism/(and) tissue formation. Helps in energy production. Helps normal growth and development. Helps normal growth. Helps to form red blood cells. Helps to maintain/support healthy mucous membranes. Helps to maintain/support normal metabolism of iron. Helps to maintain/support normal red blood cells. Helps to maintain/support the body's ability to metabolize nutrients. Supports energy production.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80144052
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.